MedCity News November 7, 2025
Check out news from Oral Genome, Amae Health, Hepta, and more.
Oral Genome is pleased to announce the appointment of Michael Shuman as Chief Revenue Officer. Shuman brings extensive experience leading high-growth organizations in the dental industry, most recently serving as CEO of Membersy, where he helped build a national footprint and drive commercial performance.
In his new role, Shuman will oversee commercial strategy, enterprise growth, and dental partnership expansion to accelerate the adoption of Oral Genome’s rapid, saliva-based testing nationwide.
“We are thrilled to welcome Michael to Oral Genome,” said Dr. Tina Saw, Founder & CEO. “His track record leading transformational growth aligns perfectly with our mission to bring preventive testing into every dental practice.”
“What drew me to...
Today's Sponsors
Today's Sponsor